E-LIB Suche - Ergebnisse für: Skarbnik, A.

1

Treatment Discontinuation Patterns for Patients With Chroni..:

Shadman, M ; Manzoor, BS ; Sail, K...
https://discovery.ucl.ac.uk/id/eprint/10171712/1/Treatment%20Discontinuation%20CLL.pdf. , 2023

Link: https://discovery.ucl.ac..

2

GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RE..:

Hutchings, M ; Avigdor, A ; Sureda, Anna...
https://portal.findresearcher.sdu.dk/da/publications/db0a9f22-f528-43f5-a3c6-7b51b1c25597. , 2023

Link: https://portal.findresea..

3

P671: TREATMENT SEQUENCES AND OUTCOMES OF PATIENTS WITH CLL..:

A. R. Mato ; B. S. Manzoor ; C. C. Coombs...
http://journals.lww.com/10.1097/01.HS9.0000845568.56124.1b. , 2022

Link: https://doi.org/10.1097/..

4

P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORA..:

J. P. Sharman ; M. Egyed ; W. Jurczak...
http://journals.lww.com/10.1097/01.HS9.0000845548.49291.01. , 2022

Link: https://doi.org/10.1097/..

5

Venetoclax retreatment of patients with chronic lymphocytic..:

Thompson, MC ; Harrup, RA ; Coombs, CC...
issn:2473-9529. , 2022

Link: http://hdl.handle.net/11..

6

The Impact of Age on Survival in CLL Patients Receiving Ibr..:

Ujjani, C ; Mato, A ; Hill, BT...
issn:1179-9889. , 2020

Link: http://hdl.handle.net/11..

7

Lisocabtagene maraleucel in follicular lymphoma: the phase ..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
10.1038/s41591-024-02986-9. , 2024

Link: https://hdl.handle.net/2..

8

Lisocabtagene maraleucel in follicular lymphoma: the phase ..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-024-02986-9. , 2024

Link: https://hal.univ-lille.f..

9

Lisocabtagene maraleucel in follicular lymphoma: the phase ..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-024-02986-9. , 2024

Link: https://hal.univ-lille.f..

10

Glofitamab Plus Polatuzumab Vedotin Continues to Demonstrat..:

Hutchings, Martin ; Avigdor, Abraham ; Sureda Balari, Anna Maria...
https://portal.findresearcher.sdu.dk/da/publications/f2b7052b-8b89-492a-bbe7-24e345b44c00. , 2023

Link: https://portal.findresea..

11

Venetoclax retreatment of patients with chronic lymphocytic..:

Thompson, Meghan C ; Harrup, Rosemary A ; Coombs, Catherine C...
https://research.vumc.nl/en/publications/dcf1cfe8-7b8c-4df5-b481-6746476ba1c1. , 2022

Link: https://research.vumc.nl..

12

Venetoclax retreatment of patients with chronic lymphocytic..:

Thompson, Meghan C ; Harrup, Rosemary A ; Coombs, Catherine C...
https://research.vumc.nl/en/publications/dcf1cfe8-7b8c-4df5-b481-6746476ba1c1. , 2022

Link: https://research.vumc.nl..

13

Recognizing Unmet Need in the Era of Targeted Therapy for C..:

Mato, Anthony R ; Davids, Matthew S ; Sharman, Jeff...
qt2fr8x6t1. , 2022

Link: https://escholarship.org..

14

Recognizing Unmet Need in the Era of Targeted Therapy for C..:

Mato, Anthony R ; Davids, Matthew S ; Sharman, Jeff...
https://research.vumc.nl/en/publications/2768a72f-69b2-444d-84cd-221ca2c9f954. , 2022

Link: https://research.vumc.nl..

15

Recognizing Unmet Need in the Era of Targeted Therapy for C..:

Mato, Anthony R ; Davids, Matthew S ; Sharman, Jeff...
https://research.vumc.nl/en/publications/2768a72f-69b2-444d-84cd-221ca2c9f954. , 2022

Link: https://research.vumc.nl..